ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07349
0,05%
Bitcoin
59.518,92
0,67%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Denali Therapeutics Inc (DNLI)

  7. Denali Therapeutics Inc (DNLI) News

DNLI Denali Therapeutics Inc

17,00
0,84 (5,20%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Denali Therapeutics Inc DNLI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,84 5,20% 17,00 00:00:45
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
16,41 15,92 16,94 16,81 16,16
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202414:00GLOBEDenali Therapeutics Announces Completion of Enrollment for..
01.3.202422:51EDGAR2Form D - Notice of Exempt Offering of Securities
27.2.202414:07EDGAR2Form 8-K - Current report
27.2.202414:05GLOBEDenali Therapeutics Reports Fourth Quarter and Full Year..
27.2.202414:03EDGAR2Form 8-K - Current report
27.2.202414:00GLOBEDenali Therapeutics Announces $500 million Private Placement..
16.2.202414:02EDGAR2Form 8-K - Current report
16.2.202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:59EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:43EDGAR2Form 144 - Report of proposed sale of securities
14.2.202402:19EDGAR2Form 144 - Report of proposed sale of securities
14.2.202402:18EDGAR2Form 144 - Report of proposed sale of securities
14.2.202402:17EDGAR2Form 144 - Report of proposed sale of securities
12.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202414:00GLOBEDenali Therapeutics Announces New Data and Expansion of Its..
01.2.202414:00GLOBEDenali Therapeutics Announces Presentations on Its..
13.1.202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:09EDGAR2Form 144 - Report of proposed sale of securities
10.1.202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202401:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202401:20EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:06EDGAR2Form 8-K - Current report
08.1.202414:00GLOBEDenali Therapeutics Announces Key Anticipated 2024..
06.1.202402:25EDGAR2Form 144 - Report of proposed sale of securities
05.1.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21.11.202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
07.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:04EDGAR2Form 8-K - Current report
07.11.202322:01GLOBEDenali Therapeutics Reports Third Quarter 2023 Financial..
01.11.202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11.9.202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30.8.202314:30GLOBEDenali Therapeutics Announces New Interim Data from Phase..
29.8.202315:00PRNUSInvaio achieves first registration for citrus greening..
25.8.202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:07EDGAR2Form 144 - Report of proposed sale of securities
23.8.202322:06EDGAR2Form 144 - Report of proposed sale of securities
21.8.202322:06EDGAR2Form 8-K - Current report
21.8.202320:47EDGAR2Form 144 - Report of proposed sale of securities
21.8.202320:45EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
DNLI
Denali Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten